Hofseth Biocare ASA
OSE:HBC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Hofseth Biocare ASA
Net Income (Common)
Hofseth Biocare ASA
Net Income (Common) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Hofseth Biocare ASA
OSE:HBC
|
Net Income (Common)
-kr134.9m
|
CAGR 3-Years
1%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-3%
|
|
|
L
|
Lytix Biopharma AS
OSE:LYTIX
|
Net Income (Common)
-kr94.3m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
|
Arcticzymes Technologies ASA
OSE:AZT
|
Net Income (Common)
kr9.9m
|
CAGR 3-Years
-33%
|
CAGR 5-Years
-35%
|
CAGR 10-Years
N/A
|
|
|
N
|
Nykode Therapeutics ASA
OSE:NYKD
|
Net Income (Common)
-$12.2m
|
CAGR 3-Years
34%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
C
|
Circio Holding ASA
OSE:CRNA
|
Net Income (Common)
-kr45.9m
|
CAGR 3-Years
53%
|
CAGR 5-Years
16%
|
CAGR 10-Years
7%
|
|
|
T
|
Thor Medical ASA
OSE:TRMED
|
Net Income (Common)
-kr58m
|
CAGR 3-Years
49%
|
CAGR 5-Years
33%
|
CAGR 10-Years
1%
|
|
Hofseth Biocare ASA
Glance View
Hofseth Biocare ASA engages in the development, marketing, and sale of biomarine ingredients. The company is headquartered in Alesund, More Og Romsdal and currently employs 63 full-time employees. The company went IPO on 2011-12-02. The Company’s business is development, manufacturing, marketing and sale of marine ingredients such as oil, calcium and protein products. Its main products are Salmon protein hydrolysate (ProGo), which is a protein for sports, endurance, and recovery powders; Fresh, all-natural salmon oil (OmeGo) that has a full spectrum of omega fatty acids, including EPA, DHA and DPA, totaling 21 different fatty acids; Calcium bone powder (CalGo) is a natural marine collagenic bone powder and CollaGo is a Collagen Peptide powder optimised to improve the beauty of hair, skin and nails. Hofseth BioCare's headquarters are in Aalesund with branches in Oslo, Chicago, Mumbai, Tokyo and Menlo Park, California.
See Also
What is Hofseth Biocare ASA's Net Income (Common)?
Net Income (Common)
-134.9m
NOK
Based on the financial report for Dec 31, 2025, Hofseth Biocare ASA's Net Income (Common) amounts to -134.9m NOK.
What is Hofseth Biocare ASA's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
-3%
Over the last year, the Net Income (Common) growth was -8%. The average annual Net Income (Common) growth rates for Hofseth Biocare ASA have been 1% over the past three years , -6% over the past five years , and -3% over the past ten years .
